Startup | August 30, 2024
Bayer awards incubator opportunity to Genvor
Critical resources will help Genvor to grow and scale biological crop protection products and innovative trait technologies
Critical resources will help Genvor to grow and scale biological crop protection products and innovative trait technologies
The successful completion of the global Phase 3 trials paves the way to obtain marketing approval in the U.S. and EU
Approval is based on data from two Phase III studies in branch and central retinal vein occlusion (RVO) showing early and sustained vision improvements non-inferior to aflibercept
Acquisition in line with Mankind’s stated objective to expand its presence in high entry barrier complex portfolios and high potential OTX brands
Susvimo is a unique therapeutic approach that provides continuous delivery of medicine to the eye through a refillable implant
Vabysmo PFS is the first and only syringe prefilled with an FDA-approved bispecific antibody to treat retinal conditions that can cause blindness
The approval of YESAFILI marks Biocon Biologics’ expansion into the ophthalmology therapeutic area in the United States
The JV successfully leveraged the strengths of both companies to better serve the fast-growing Indian market
Keimed is a leading wholesale pharma distribution with industry leading operating metrics
Vericiguat works on a pathway not currently targeted by existing heart failure treatments
Subscribe To Our Newsletter & Stay Updated
